Phosphorylation Analysis of G Protein-Coupled Receptor by Mass

Jun 26, 2008 - Phosphorylation plays vital roles in the regulation and function of the V2 vasopressin receptor (V2R), a G protein-coupled receptor (GP...
0 downloads 0 Views 413KB Size
Download PDF
Anal. Chem. 2008, 80, 6034–6037

Phosphorylation Analysis of G Protein-Coupled Receptor by Mass Spectrometry: Identification of a Phosphorylation Site in V2 Vasopressin Receptor Shilan Wu,† Mariel Birnbaumer,† and Ziqiang Guan*,‡ Laboratory of Signal Transduction, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709, and Department of Biochemistry, Duke University Medical Center, Durham, North Carolina 27710 Phosphorylation plays vital roles in the regulation and function of the V2 vasopressin receptor (V2R), a G protein-coupled receptor (GPCR) that is responsible for maintaining water homeostasis in the kidney. Through a combination of immunoaffinity purification, immobilized metal affinity chromatography, and nanoflow liquid chromatography tandem mass spectrometry, we identified a novel phosphorylation site (Ser255) in the third intracellular loop of human V2R. We showed that the third intracellular loop could be phosphorylated in vitro by protein kinase A, but not by Akt kinase, although sequence motif analysis predicated otherwise. The analytical procedures and methodologies described in this study should be generally applicable for identifying the endogenous phosphorylation sites in other GPCRs, overcoming the limitations of conventional approaches such as sequence motif analysis and site-directed mutagenesis. Phosphorylation plays vital roles in the regulation and function of G protein-coupled receptors (GPCR), a large family of seven transmembrane receptors that sense molecules outside the cell and activate inside signal transduction pathways. For example, phosphorylation is a crucial mechanism in turning off receptor signaling as first described for rhodopsin.1 The phosphorylation that leads to receptor uncoupling from G proteins is catalyzed by GPCR kinases (GRKs) that recognize the receptor as substrate after agonist binding.2 This phosphorylation often modifies the cytosolic C-terminal tail and leads to arrestin binding and receptor internalization.2 Phosphorylation of GPCRs by protein kinase A (PKA) or protein kinase C has also been reported,3–5 the activation of these kinases is the consequence of signaling triggered by the receptor after ligand binding. Sequence motif analysis was previously used to predict the putative phosphorylation sites in * To whom correspondence should be addressed. Fax: +1 919 684 8885. E-mail: [email protected]. † National Institute of Environmental Health Sciences. ‡ Duke University Medical Center. (1) Hurley, J. B.; Spencer, M.; Niemi, G. A. Vision Res. 1998, 38, 1341–1352. (2) Pitcher, J. A.; Freedman, N. J.; Lefkowitz, R. J. Annu. Rev. Biochem. 1998, 67, 653–692. (3) Innamorati, G.; Sadeghi, H.; Birnbaumer, M. J. Biol. Chem. 1998, 273, 7155–7161. (4) Olivares-Reyes, J. A.; Jayadev, S.; Hunyady, L.; Catt, K. J.; Smith, R. D. Mol. Pharmacol. 2000, 58, 1156–1161. (5) Oppermann, M.; Freedman, N. J.; Alexander, R. W.; Lefkowitz, R. J. J. Biol. Chem. 1996, 271, 13266–13272.

6034

Analytical Chemistry, Vol. 80, No. 15, August 1, 2008

GPCRs. In several instances, the predicted phosphorylation sites were confirmed by in vitro experiments. V2 vasopressin receptor (V2R) is a GPCR that is responsible for maintaining water homeostasis in the kidney. V2R has been shown to be subjected to homologous but not to heterologous desensitization mediated by PKA, opposite to the β2 adrenergic receptor.6 V2R is known to couple to G proteins and stimulate adenylyl cyclase activity, but contrary to what happens with other receptors, activation of PKA by the increased levels of cAMP did not change the coupling ability of the receptor.6 From sequence motif analysis, the human V2R does not contain a PKA canonical acceptor site. Previous studies, by a combination of deletion, sitedirected mutagenesis and phosphorylation carried out in intact cells, identified nine possible sites clustered at the C-terminal tail (Ser357, Thr359, Thr360, Ser362, Ser363, Ser364, Thr369, Ser370, Ser371) that seem to be phosphorylated by GRKs.7,8 Although the approaches employed in these studies have been useful for studying GPCR phosphorylation, there are major limitations. For example, mutagenesis may alter the endogenous phosphorylation states. The mass spectrometry-based approach, with its high sensitivity and specificity, has been increasingly applied to the protein phosphorylation analysis.9–12 Through tandem mass spectrometry (MS), the amino acid sequence and phosphorylation sites can be determined simultaneously and unequivocally. Moreover, the improved enrichment of the phosphopepitdes by using immobilized metal affinity chromatography (IMAC) allowed the detection of the less abundant phosphorylation sites.9–12 In this study, we applied immunoaffinity purification, IMAC, and nanoflow liquid chromatography/tandem mass spectrometry to identify the V2R residues that are phosphorylated under arginine vasopressin (AVP) stimulation and identified a novel PKA phosphorylation site in the third intracellular loop of V2R. (6) Birnbaumer, M.; Antaramian, A.; Themmen, A. P.; Gilbert, S. J. Biol. Chem. 1992, 267, 11783–11788. (7) Innamorati, G.; Sadeghi, H.; Eberle, A. N.; Birnbaumer, M. J. Biol. Chem. 1997, 272, 2486–2492. (8) Innamorati, G.; Sadeghi, H. M.; Tran, N. T.; Birnbaumer, M. Proc. Natl. Acad. Sci. U. S. A. 1998, 95, 2222–2226. (9) Ficarro, S. B.; McCleland, M. L.; Stukenberg, P. T.; Burke, D. J.; Ross, M. M.; Shabanowitz, J.; Hunt, D. F.; White, F. M. Nat. Biotechnol. 2002, 20, 301–305. (10) Garcia, B. A.; Shabanowitz, J.; Hunt, D. F. Methods 2005, 35, 256–264. (11) Cantin, G. T.; Shock, T. R.; Park, S. K.; Madhani, H. D.; Yates, J. R., 3rd Anal. Chem. 2007, 79, 4666–4673. (12) Cantin, G. T.; Yi, W.; Lu, B.; Park, S. K.; Xu, T.; Lee, J. D.; Yates, J. R., 3rd J. Proteome Res. 2008, 7, 1346–1351. 10.1021/ac8008548 CCC: $40.75  2008 American Chemical Society Published on Web 06/26/2008

EXPERIMENTAL METHODS Materials. DMEM, penicillin/streptomycin, 0.5% trypsin/5 mM EDTA, and fetal bovine serum (FBS) were from Invitrogen (Carlsbad, CA). Complete protease inhibitor cocktail was from Roche (Indianapolis, IN). AVP and 3-isobutyl-1-methylxanthine were from Sigma (St. Louis, MO). [3H]-AVP (specific activity, 44 Ci/mmol), [R-32P]-ATP (specific activity, 3000 Ci/mmol) and [γ-32P]-ATP (specific activity, 3000 Ci/mmol) were from PerkinElmer (Wellesley, MA). [3H]-cAMP (specific activity, 44 Ci/ mmol) was from Amersham (Arlington Heights, IL). All other reagents were obtained from Sigma. Cell Culture. HEK 293 cells stably expressing HA-tagged V2R were grown in DMEM-high glucose, supplemented with 10% heatinactivated FBS, penicillin (50 units/mL), and streptomycin (50 mg/ mL). Immunoaffinity Purification and Trypsin Digestion of HATagged V2R. Fifteen 15-cm dishes of stably transfected cells expressing the HA-tagged V2R were treated with 10 nM AVP at 37 °C for 20 min. The plates were washed twice with PBS and lysed for 20 min on ice with 1.5 mL/dish RIPA buffer containing protease inhibitors and phosphatase inhibitors. The cells were scraped off the dishes and homogenized in a Dounce homogenizer with 20 strokes of a tight-fitting pestle followed by two sonication treatments of 30 s each. The cell lysate was centrifuged in a 50mL centrifuge tube at 1200g for 10 min to remove cellular debris. After transferring the supernatant to a new 50-mL centrifuge tube, the supernatant was mixed with 150 µL of antimouse IgG beads for 4 h at 4 °C and then centrifuged at 1200g for 10 min. The supernatant was transferred to a fresh tube, mixed with 150 µL of anti-HA agarose beads, and incubated overnight at 4 °C. The beads were spun down at 1200g for 10 min and transferred to a 1.5-mL siliconized microcentrifuge tube. The beads were then washed three times with 1 mL of RIPA buffer with phosphatase inhibitors, followed by three washes with 1 mL of wash buffer (50 mM Tris-HCL pH 8.0, 150 mM NaCl, 1% NP-40) with phosphatase inhibitors. After loading the beads into a Bio-Rad Poly-Prep column (i.d. 0.8 cm, length 4 cm), the bound proteins were eluted with 600 µL of 0.1 M glycine-HCl, pH 2.5 into a 1.5mL siliconized microcentrifuge tube containing 24 µL of 1 M TrisHCl pH 8.0 for neutralization. The eluate (∼600 µL) was reduced with 4 µL of 100 mM dithiothreitol (DTT) at 57 °C for 1 h and subsequently alkylated with 10 µL of 100 mM iodoacetamide at room temperature for 45 min in the dark. After neutralization of the iodoacetamide by 20 µL of 100 mM DTT for 1 h at room temperature, 5 µL of trypsin (200 µg/mL) was added. After overnight digestion at 37 °C, the reaction was terminated by the addition of 10 µL of glacial acetic acid. Immobilized Metal Affinity Chromatography and Nanoflow Liquid Chromatography/Tandem Mass Spectrometry. Immobilized metal affinity chromatography (IMAC) was performed according to Ficarro et al.,9 with minor modifications. A 200-µm o.d. × 100-µm i.d. fused-silica column (Polymicro Technologies, Phoenix, AZ) was packed with 8 cm of Poros 20 MC (PerSeptive Biosystems, Framingham, MA). The column was activated with 100 mM FeCl3 and rinsed with 0.1% acetic acid to remove excess metal ions and to equilibrate the column. About 50 µL of the V2R tryptic digest (out of ∼600 µL total) was then loaded onto the IMAC column. To remove nonspecific binding

peptides, the column was washed with a solution of NaCl (100 mM) in acetonitrile, water, and glacial acetic acid (25:74:1, v/v). The column was then equilibrated with 0.1% acetic acid. For MS analysis, the IMAC column was connected to a fused-silica column of 200-µm o.d. × 100-µm i.d. packed with 8 cm of Poros 10 R2 (Applied Biosystems, Foster City, CA). All column connections were made using 1 cm of 0.012-in. i.d. × 0.060-in. o.d. Teflon tubing (Zeus, Orangeburg, SC). Phosphopeptides were eluted onto the reversed-phase column with 10 µL of 200 mM Na2HPO4. The reversed-phase column was then disconnected from the IMAC column and rinsed with several column volumes of 0.1% acetic acid to remove Na2HPO4. The tryptic phosphopepitdes enriched by IMAC were analyzed by nanoflow liquid chromatography (LC)/MS/MS using a QSTAR XL quadrupole time-of-flight tandem mass spectrometer (ABI/ MDS-Sciex, Forster City, CA). The MS/MS spectra were acquired in information-dependent acquisition (IDA) mode. The HPLC gradient consists of holding at 0% solvent B for 3 min, followed by increasing to 15% solvent B in 3 min, and then to 55% solvent B in 24 min. Solvent A consists of water/acetonitrile (98:2, v/v) with 0.1% acetic acid. Solvent B consists of acetonitrile/water (90: 10, v/v) with 0.1% acetic acid. A flow rate of ∼200 nL/min was used to elute the peptides from the reversed-phase column into the ionization source of the mass spectrometer. Mass spectra were acquired in the IDA mode. Collision-induced dissociation mass spectra were searched against the SWISS-PROT protein database by using the ProID algorithm (ABI/MDS-Sciex). Expression and Purification of Glutathione S-Transferase (GST)-3rd Intracellular Loop of V2R and in Vitro AKT and PKA Kinase Assays. A segment of human V2R encoding amino acid residues 232-271 was synthesized via PCR and subcloned into pGEX-4T. The GST fusion protein was purified to homogeneity by affinity chromatography using glutathione-agarose beads (Sigma) as described by Smith and Johnson.13 The purified fusion proteins (GST or GST-3rd intracellular loop of V2R) were dialyzed extensively against PBS. About 1 µg of GST or GST-3rd intracellular loop of V2R proteins was incubated at 30 °C for 20 min in 25 µL of kinase buffer (pH 7.5) containing 25 mM Tris-HCl, 10 mM MgCl2, 2 mM DTT, 5 mM β-glycerophosphate, 0.1 mM Na3VO4, 50 µM ATP, 10 µCi of [γ-32P]-ATP and 50 ng of either protein kinase A catalytic subunit β (Sigma) or GST-Akt fusion protein from Cell Signaling Technology, Inc. (Danvers, MA). The kinase activity of PKA was tested using Kemptide as a substrate, and the kinase activity of Akt was tested using GSK3 (14-27) peptide as a substrate. The reactions were then stopped by adding 6.5 µL of 5 × SDS gel loading buffer. Proteins were subjected to the analysis by SDS-PAGE, Coomassie blue staining, and autoradiography. RESULTS AND DISCUSSION To identify the human V2R residues that are phosphorylated under AVP stimulation, we treated the stably transfected HEK293 cells with 10 nM AVP for 20 min. Purification of human V2R was accomplished by immunoprecipitation of HA-hV2R using a monoclonal anti-HA agarose conjugated antibody. Following reduction and alkylation as described in the Experimental Section, the purified receptors were digested with trypsin overnight. The (13) Smith, D. B.; Johnson, K. S. Gene 1988, 67, 31–40.

Analytical Chemistry, Vol. 80, No. 15, August 1, 2008

6035

Figure 1. MS/MS identification of a tryptic phosphopeptide of V2R. The phosphopeptide is derived from the trypsin digestion of the immunoaffinitypurified V2R and identified by searching its MS/MS spectra ([M + 3H] 3+ at m/z 506.9 shown in the inset) against the SWISS-PROT database using the ProID software. The amino acid sequence of the phosphopeptide is 253TGpSPGEGAHVSAAVAK268 (pS denotes a phosphorylated serine). The underlined are the observed b/y sequence ions (or their corresponding H3PO4-loss ions) that are predicted from the amino acid sequence (Top).

resulting tryptic phosphopeptides were enriched by IMAC,9,14,15 followed by the analysis using nanoflow reversed-phase HPLC coupled with a high-resolution tandem mass spectrometer (QSTAR XL). Tandem MS spectra were searched against the SWISS-PROT database using the ProID algorithm, yielding the identification of a tryptic phosphopeptide (253TGpSPGEGAHVSAAVAK268) derived from the human V2R. Figure 1 shows the MS/ MS spectrum of the triply charged ion ([M + 3H]3+) of this phosphopeptide. The assignment of phosphorylation site at Ser255 is further verified by both N- and C-terminal product ions (b2, b3, y13, y14, and y15) containing Ser255. All sequenceinformative product ions are listed in Table 1. This phosphopeptide could only be detected when cells were treated with AVP, suggesting Ser255 phosphorylation is ligand-dependent event. We did not detect any other V2R phosphopeptides, including the putative phosphopeptides from the C-terminal tail. It is possible that the phosphopeptides derived from the C-terminal tail of V2R are hyperphosphorylated and are too hydrophilic to be retained on the reversed-phase matrixes.9 This is a limitation that still needs to be addressed. Sequence analysis revealed that Ser255 is conserved in the V2R orthologs of mouse, rat, cattle, dog, pig, and horse. To predict which kinase could phosphorylate Ser255, we examined the fulllength receptor protein using Motif Scan software from MIT (http://scansite.mit.edu/motifscan_seq.phtml). Under medium (14) Andersson, L.; Porath, J. Anal. Biochem. 1986, 154, 250–254. (15) Muszynska, G.; Andersson, L.; Porath, J. Biochemistry 1986, 25, 6850– 6853.

6036

Analytical Chemistry, Vol. 80, No. 15, August 1, 2008

Table 1. MS/MS Product Ions of the [M + 3H]3+ Ion of a V2R Tryptic Phosphopeptide, 253TGpSPGEGAHVSAAVAK268a

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

residue

immonium ion

a

b

T G pS P G E G A H V S A A V A K

74.1

74.0 131.1 298.1 395.1

102.6 159.1 326.1

140.0 70.1

y

y-NH3

1417.6 1360.6 1193.6 1096.6

102.1 709.3 110.1 72.1

72.1 101.1

782.5 645.4 546.3 459.3 388.3 317.2 218.1 147.1

371.2 201.1 130.1

a These product ions are identified by database searching using the ProID algorithm and verified by manual examination.

stringency, the software predicted Akt as a potential kinase for Ser255, whereas under low stringency, the software added PKA as an additional kinase for Ser255. The kinase activities of Akt and PKA toward Ser255 were measured using an in vitro kinase assay with the purified GST-3rd intracellular loop of V2R as a substrate. As shown in Figure 2, the GST-3rd intracellular loop of V2R was phosphorylated by PKA (lane 5) but not by Akt (lane 2). Although the Gs/adenylyl cyclase signaling pathway makes PKA a likely

Figure 2. Phosphorylation of the GST-3rd intracellular loop of V2R. Equal amounts (∼1 µg) of GST (lanes 1 and 4) or GST-3rd intracellular loop of V2R (lanes 2 and 5) were incubated with either Akt (lanes 1 and 2) or PKAcβ (lanes 4 and 5) in the presence of [γ-32P]-ATP. Lanes 3 and 6 show the autophosphorylation of Akt and PKA, respectively.

effects on receptor folding, ligand binding, internalization, and recycling.20–23 Given the recent crystal structure of β2AR lacks the native third intracellular loop (modified for crystallization purpose),24 the structure and function of the third intracellular loop of GPCRs may deserve more research attention. In conclusion, we carried out endogenous phosphorylation analysis of GPCR through immunoaffinity purification, immobilized metal affinity chromatography, and nanoflow LC/MS/MS and identified a novel, AVP-dependent phosphorylation site (Ser255) in the third intracellular loop of V2R. We demonstrated that Ser255 could be phosphorylated by PKA in vitro. The analytical strategies demonstrated in this study should be generally applicable to the identification of novel phosphorylation sites in other GPCRs, overcoming the limitations of conventional approaches such as sequence motif analysis and site-directed mutagenesis. Figure 3. Schematic diagram of V2R. The Ser255-containing phosphopeptide is located in the third intracellular loop.

kinase for V2R, this is the first time that a PKA phosphorylation site has been identified in V2R. β2 adrenergic receptor (β2AR) has been shown to be phosphorylated by PKA at a canonical PKA site (RRSS) in the third intracellular loop.16 However, the same canonical PKA site (RRSS) does not exist in V2R. According to Kennelly and Krebs,17 Ser255 is a noncanonical PKA phosphorylation site (RRXXS). All previously proposed phosphorylation sites in V2R are located within the C-terminal tail and have been shown to inhibit receptor recycling upon ligand removal.8,18 Mutagenesis of single serines or threonines in the C-terminal tail reduced phosphorylation to different degrees and had variable effects on V2R recycling.8,19 Ser255 represents the first phosphorylation site identified in the third intracellular loop of V2R (Figure 3). Functional studies of Ser255 phosphorylation may include the evaluation of its (16) Hausdorff, W. P.; Bouvier, M.; O’Dowd, B. F.; Irons, G. P.; Caron, M. G.; Lefkowitz, R. J. J. Biol. Chem. 1989, 264, 12657–12665. (17) Kennelly, P. J.; Krebs, E. G. J. Biol. Chem. 1991, 266, 15555–15558. (18) Le Gouill, C.; Innamorati, G.; Birnbaumer, M. FEBS Lett. 2002, 532, 363– 366. (19) Innamorati, G.; Le Gouill, C.; Balamotis, M.; Birnbaumer, M. J. Biol. Chem. 2001, 276, 13096–13103.

ACKNOWLEDGMENT We thank Dr. Lutz Birnbaumer for advice, Dr. Christian Raetz for support, and Diana Walstad, Brian Waldron, Dagoberto Grenet, and Oliver Guan for technical assistance and inspiration. This research was supported in part by the Intramural Research Program of the National Institute of Environmental Health Sciences. The mass spectrometry facility in the Department of Biochemistry of Duke University Medical Center was supported by the LIPID MAPS glue grant (GM-069338) from the National Institutes of Health. Received for review April 27, 2008. Accepted May 28, 2008. AC8008548 (20) Birnbaumer, M.; Gilbert, S.; Rosenthal, W. Mol. Endocrinol. 1994, 8, 886– 894. (21) Erlenbach, I.; Wess, J. J. Biol. Chem. 1998, 273, 26549–26558. (22) Gouill, C. L.; Darden, T.; Madziva, M. T.; Birnbaumer, M. FEBS Lett. 2005, 579, 4985–4990. (23) Tan, C. M.; Brady, A. E.; Nickols, H. H.; Wang, Q.; Limbird, L. E. Annu. Rev. Pharmacol. Toxicol. 2004, 44, 559–609. (24) Rasmussen, S. G.; Choi, H. J.; Rosenbaum, D. M.; Kobilka, T. S.; Thian, F. S.; Edwards, P. C.; Burghammer, M.; Ratnala, V. R.; Sanishvili, R.; Fischetti, R. F.; Schertler, G. F.; Weis, W. I.; Kobilka, B. K. Nature 2007, 450, 383–387.

Analytical Chemistry, Vol. 80, No. 15, August 1, 2008

6037